As futures increase stock futures, merger news concentrates; Oracle share jump


Stock futures moved towards a higher open area on Monday morning as investors contemplated positive growth around the coronovirus vaccine candidate, and saw the buzz of newly announced mergers and acquisitions among major companies.

AstraZeneca (AZN) announced over the weekend that its late-stage Kovid-19 vaccine trials with the University of Oxford had been resumed, a week before the company temporarily withdrew due to safety concerns over a suspected adverse reaction from a participant The trial was stopped. Shares gained nearly 0.5% in early trade.

Somewhere, Oracle (ORCL) shares rose 9% in early trading, according to reports from several news outlets, with the tech company partnering with Tiktok’s US business unit, which included Microsoft (MSFT) , Previously seen as a frontrunner. An alliance with a fast-growing social media company. Microsoft shares declined in pre-market trading on Friday.

“Global markets are on an optimistic move, with M&A activity and vaccine development helping spirits to lift spirits after a recent decline,” Josh Mahoney, senior market analyst at IG, wrote in an email on Monday.

He said that the development between Oracle and Tiktok helps reduce friction between the US and China, yet there will be questions on how much data is available for the main unit. “On the vaccine front, the AstraZeneca vaccine trial is reported to resume, following fears that complications with one participant may represent a significant barrier to development. Trump said a vaccine was expected before the election States have been told to do that we are directly at home for an effective treatment. “

Other major corporations also announced massive new deals over the weekend. Chipmaker Nvidia (NVDA) announced that it was buying Softbank Group’s chip unit Arm Limited for $ 40 billion in transactions – the largest ever in the semiconductor industry. Elsewhere, Gilead Sciences (GILD) agreed to buy Immunomedics (IMMU) in a deal worth about $ 21 billion, which is later adding tumor-fighting drugs to the pharmaceutical giant’s portfolio. Gilead shares fell 1% in early trading, while Immunomedics’ stock more than doubled.

7:19 am ET Monday: Stock futures rise as vaccine, focused on M&A growth

There were major moves in the markets here, such as 7:19 AM ET:

  • S&P 500 Futures (ES = F): 3,3374.00, up 40.25 points or 1.21%

  • Dow Futures (YM = F): 27,850.00, up 238.00 points or 0.86%

  • Nasdaq Futures (NQ = F): 11,241.5, 180.00 points or 1.63%

  • Crude (Cl = f): – $ 0.11 (-0.29%) to $ 37.22 per barrel

  • Gold (Gc = f): + $ 4.00 (+ 0.21%) to $ 1,951.90 per ounce

  • 10 Year Treasure (^ TNX): 0.674% yield from +0.7 bp

A trader working on the floor of the New York Stock Exchange (NYSE) is shown on a monitor on October 10, 2018 in Manhattan, New York, USA. REUTERS / Brendan McDermid

Follow yahoo finance Twitter, Facebook, Instagram, Flipboard, Linkedin, And reddit.

Get live stock market quotes and latest business and finance news

For tutorials and information on investing and trading stocks, see Cashay